Anuja N. Mehta Ph.D.

Associate

San Diego + 1.858.703.3130

Dr. Anuja Mehta's practice involves domestic and foreign patent portfolio development, management, and enforcement in various areas of life sciences including molecular and cellular biology, antibody therapeutics, pharmaceuticals, cell therapies, vaccines, and microbial biology.

Anuja advises clients regarding patentability, validity, infringement, and freedom-to-operate issues and performs due diligence evaluations of patent portfolios in connection with venture capital and private equity financings, collaborations, and/or partnering deals.

Her practice also includes various post-grant proceedings before the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office (USPTO), including inter partes reviews (IPRs).

Her current representative clients include Janssen Biotech, Merck, NGM Biopharmaceuticals, Epic Sciences, and Bellicum Pharmaceuticals, as well as other start-up companies, established companies, academic institutions, and investment firms.

Prior to joining Jones Day in 2016, Anuja obtained her Ph.D. in molecular and cell biology in the lab of Prof. James E. Haber at Brandeis University. She has authored several peer-reviewed publications and has served in several leadership roles throughout her academic studies.